药明康德更新2025年第二季度股票回购进展,完成10亿元人民币A股回购及25亿港元H股购买,以提升股东价值和吸引人才。
Source Link药明康德更新2025年第二季度股票回购进展,完成10亿元人民币A股回购及25亿港元H股购买,以提升股东价值和吸引人才。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.